A detailed history of Jackson, Grant Investment Advisers, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Jackson, Grant Investment Advisers, Inc. holds 2,799 shares of LLY stock, worth $2.09 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares
2,799
Previous 2,796 0.11%
Holding current value
$2.09 Million
Previous $2.53 Million 2.05%
% of portfolio
0.94%
Previous 1.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$772.14 - $960.02 $2,316 - $2,880
3 Added 0.11%
2,799 $2.48 Million
Q2 2024

Jul 16, 2024

SELL
$724.87 - $909.04 $149,323 - $187,262
-206 Reduced 6.86%
2,796 $2.53 Million
Q1 2024

May 08, 2024

BUY
$592.2 - $792.28 $2,368 - $3,169
4 Added 0.13%
3,002 $2.34 Million
Q4 2023

Feb 01, 2024

BUY
$525.19 - $619.13 $2,100 - $2,476
4 Added 0.13%
2,998 $1.75 Million
Q3 2023

Oct 13, 2023

SELL
$434.7 - $599.3 $207,786 - $286,465
-478 Reduced 13.77%
2,994 $1.61 Million
Q2 2023

Aug 01, 2023

SELL
$350.74 - $468.98 $82,423 - $110,210
-235 Reduced 6.34%
3,472 $1.63 Million
Q1 2023

May 02, 2023

SELL
$310.63 - $364.82 $33,548 - $39,400
-108 Reduced 2.83%
3,707 $1.27 Million
Q4 2022

Jan 26, 2023

BUY
$321.55 - $374.67 $1,607 - $1,873
5 Added 0.13%
3,815 $0
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $1,482 - $1,689
5 Added 0.13%
3,810 $1.23 Million
Q2 2022

Aug 04, 2022

BUY
$278.73 - $327.27 $1,393 - $1,636
5 Added 0.13%
3,805 $1.23 Million
Q1 2022

Apr 28, 2022

BUY
$234.69 - $291.66 $1,408 - $1,749
6 Added 0.16%
3,800 $1.09 Million
Q4 2021

Jan 24, 2022

BUY
$224.85 - $279.04 $2,248 - $2,790
10 Added 0.26%
3,794 $1.05 Million
Q3 2021

Oct 13, 2021

BUY
$221.6 - $272.71 $1,551 - $1,908
7 Added 0.19%
3,784 $874,000
Q2 2021

Jul 15, 2021

BUY
$180.55 - $233.54 $2,347 - $3,036
13 Added 0.35%
3,777 $867,000
Q1 2021

Apr 22, 2021

BUY
$164.32 - $212.72 $1,807 - $2,339
11 Added 0.29%
3,764 $703,000
Q4 2020

Mar 03, 2021

BUY
$130.46 - $172.63 $33,658 - $44,538
258 Added 7.38%
3,753 $634,000
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $1,900 - $2,198
13 Added 0.37%
3,495 $517,000
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $2,046 - $2,462
15 Added 0.43%
3,482 $572,000
Q1 2020

May 12, 2020

BUY
$119.05 - $147.35 $2,261 - $2,799
19 Added 0.55%
3,467 $481,000
Q4 2019

Feb 05, 2020

SELL
$106.92 - $132.43 $2,673 - $3,310
-25 Reduced 0.72%
3,448 $453,000
Q3 2019

Nov 20, 2019

BUY
$106.79 - $116.16 $2,029 - $2,207
19 Added 0.55%
3,473 $388,000
Q2 2019

Aug 13, 2019

BUY
$110.79 - $129.32 $2,105 - $2,457
19 Added 0.55%
3,454 $383,000
Q1 2019

May 07, 2019

BUY
$111.31 - $131.02 $1,892 - $2,227
17 Added 0.5%
3,435 $446,000
Q4 2018

Jan 23, 2019

SELL
$105.9 - $118.64 $36,641 - $41,049
-346 Reduced 9.19%
3,418 $395,000
Q3 2018

Nov 15, 2018

BUY
$85.86 - $107.31 $1,717 - $2,146
20 Added 0.53%
3,764 $404,000
Q2 2018

Aug 02, 2018

BUY
$75.7 - $86.88 $1,892 - $2,172
25 Added 0.67%
3,744 $319,000
Q1 2018

May 14, 2018

BUY
$74.21 - $87.6 $2,003 - $2,365
27 Added 0.73%
3,719 $288,000
Q4 2017

Feb 01, 2018

BUY
$81.94 - $87.89 $1,802 - $1,933
22 Added 0.6%
3,692 $312,000
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $1,772 - $1,967
23 Added 0.63%
3,670 $314,000
Q2 2017

Aug 10, 2017

BUY
N/A
3,647
3,647 $300,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Jackson, Grant Investment Advisers, Inc. Portfolio

Follow Jackson, Grant Investment Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson, Grant Investment Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jackson, Grant Investment Advisers, Inc. with notifications on news.